Synthesis, drug release and anti-HIV activity of a series of PEGylated zidovudine conjugates

Wenjun Li; Jingde Wu; Peng Zhan; Yu Chang; Christophe Pannecouque; De Clercq Erik; Xinyong Liu

doi:10.1016/j.ijbiomac.2012.02.019

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2011

Synthesis, Influence of Polymer Molecular Weight on Drug Release and Anti-HIV Activity of PEGylated AZT Conjugates

Wenjun Li, Peng Zhan, Jingde Wu, Yu Chang, Christophe Pannecouque, De Clercq Erik, Xinyong Liu

Article2000

Anti-HIV activity of a series of cosalane amino acid conjugates

K. C. Santhosh, De Clercq Erik, Christophe Pannecouque, Myriam Witvrouw, Tracy L. Loftus, Jim A. Turpin, Robert W. Buckheit, Mark Cushman

Article2010

Synthesis, In Vitro and In Vivo Release Kinetics, and Anti‐HIV Activity of A Sustained‐Release Prodrug (mPEG‐AZT) of 3′‐Azido‐3′‐deoxythymidine (AZT, Zidovudine)

Wenjun Li, Yu Chang, Peng Zhan, Na Zhang, Xinyong Liu, Christophe Pannecouque, De Clercq Erik

Article1996

Preparation and characterization of conjugates of (modified) human serum albumin and liposomes: drug carriers with an intrinsic anti-HIV activity

Jan A. A. M. Kamps, Pieter Swart, Henriëtte W. M. Morselt, Rudi Pauwels, Marie-Pierre De Béthune, De Clercq Erik, Dirk K. F. Meijer, Gerrit L. Scherphof

Article1998

Anti-HIV-1 activity of combinations and covalent conjugates of negatively charged albumins and AZT

Myriam Witvrouw, José A. Esté, De Clercq Erik, Dirk Meijer